Drugs - Real World Outcomes

SJR Rank #8,807H-index: 27SJR: 0.662Best quartile: Q2Open AccessAPC: US$3,090Listed in DOAJ
Journal website: aims, scope and author guidelines
Publisher

Country

Switzerland

Type

journal

SJR by Edition

2022202500.20.40.60.8

Subject Categories

  • Pharmacology (medical)Q2

Areas: Medicine

Most published research topics

Pharmacovigilance and Adverse Drug ReactionsPharmaceutical Practices and Patient OutcomesMedication Adherence and ComplianceHeart Failure Treatment and ManagementRheumatoid Arthritis Research and TherapiesAntibiotic Use and ResistanceSchizophrenia research and treatmentAtrial Fibrillation Management and OutcomesOpioid Use Disorder TreatmentDiabetes Treatment and Management

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs050100150200

Documents per Year

20222025020406080

Detailed Information

ISSN

2199-1154, 2198-9788

SJR Best Quartile

Q2

Region

Western Europe

Citations per Document (2 years)

2.07

References per Document

34.91

Coverage

2014-2026

Scope

Drugs - Real World Outcomes targets original research and definitive reviews regarding the use of real-world data to evaluate health outcomes and inform healthcare decision-making on drugs, devices and other interventions in clinical practice. The journal includes, but is not limited to, the following research areas: Using registries/databases/health records and other non-selected observational datasets to investigate: drug use and treatment outcomes prescription patterns drug safety signals adherence to treatment guidelines benefit : risk profiles comparative effectiveness economic analyses including cost-of-illness Data-driven research methodologies, including the capture, curation, search, sharing, analysis and interpretation of ‘big data’ Techniques and approaches to optimise real-world modelling.

Metrics from SCImago Journal Rank 2025. View on SCImago